Lonza Group AG | LONN Annual Report & Investor Relations Data
ISIN
CH0013841017
Ticker
LONN
Sector
Industry
Country
Switzerland
Year Founded
1897
ISIN
CH0013841017
Ticker
LONN
Sector
Industry
Country
Switzerland
Year Founded
1897
Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.
16,218
Worldwide
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
Limited spots available. Join now!
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 26.07.2024 | None | Executive member | Sell | CHF 229,668.80 |
| 15.11.2023 | None | Executive member | Buy | CHF 7,088.00 |
| 01.11.2023 | None | Executive member | Buy | CHF 95,927.90 |
| 23.10.2023 | None | Executive member | Buy | CHF 327.30 |
| 19.10.2023 | None | Executive member | Buy | CHF 19,847.60 |
| 18.10.2023 | None | Non-Executive member | Buy | CHF 495,880.00 |
| 18.10.2023 | None | Executive member | Buy | CHF 19,481.00 |
| 23.05.2023 | None | Executive member | Sell | CHF 533,504.40 |
| 19.05.2023 | None | Executive member | Sell | CHF 298,737.20 |
| 27.01.2022 | None | Executive member | Buy | CHF 59,163.24 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
CH0013841017
549300EFW4H2TCZ71055
SMI
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …
AB
Sector
Health Care
Country
France
ISIN
FR0010557264
Founded
2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …
ALACT
Sector
Health Care
Country
France
ISIN
FR0014005OJ5
Founded
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …
ACTI
Sector
Health Care
Country
Sweden
ISIN
SE0001137985
Founded
1998
Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …